X4 Pharmaceuticals: HC Wainwright Raises Buy Rating to $5, PT from $3.5

Monday, Nov 10, 2025 7:17 am ET1min read
XFOR--

X4 Pharmaceuticals: HC Wainwright Raises Buy Rating to $5, PT from $3.5

X4 Pharmaceuticals: HC Wainwright Raises Buy Rating to $5, PT from $3.5

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet